Status:
WITHDRAWN
Combination Therapy for Neovascular Age Related Macular Degeneration
Lead Sponsor:
Yonsei University
Conditions:
Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Exudative age related macular degeneration (ARMD) is most common cause of blindness in old population. It is clear that no single therapy addresses the multifactorial pathogenesis of the disease. Rece...
Eligibility Criteria
Inclusion
- Neovascular ARMD confirmed with 90+ noncontact lens biomicroscopy, fluorescein angiography, ocular coherence tomography
Exclusion
- Intractable systemic hypertension
- Recent myocardial infarct within 6 months at enrollment
- Recent cerebrovascular attack within 6 months
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00447031
Start Date
March 1 2007
End Date
November 1 2007
Last Update
February 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Yonsei University College of Medicine
Seoul, South Korea, 120-752